Related Experiment Video
Updated: May 16, 2026
A Permanent Window for Investigating Cancer Metastasis to the Lung
Published on: July 1, 2021
Year-in-Review of Lung Cancer
1Department of Internal Medicine, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea.
Abstract:
In the last several years, we have made slow but steady progress in understanding molecular biology of lung cancer. This review is focused on advances in understanding the biology of lung cancer that have led to proof of concept studies on new therapeutic approaches. The three selected topics include genetics, epigenetics and non-coding RNA. This new information represents progress in the integration of molecular mechanisms that to identify more effective ways to target lung cancer.
Insights
Recent advances in lung cancer research reveal key insights into its molecular biology. Understanding genetics, epigenetics, and non-coding RNA offers new therapeutic targets for more effective lung cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer remains a leading cause of cancer-related mortality worldwide.
- Significant progress has been made in understanding the molecular underpinnings of lung cancer.
- Identifying novel therapeutic targets is crucial for improving patient outcomes.
Purpose of the Study:
- To review recent advances in the molecular biology of lung cancer.
- To highlight how these advances inform new therapeutic strategies.
- To focus on genetics, epigenetics, and non-coding RNA in lung cancer.
Main Methods:
- Literature review of recent studies on lung cancer molecular biology.
- Analysis of research focusing on genetic alterations in lung cancer.
- Examination of epigenetic modifications and their role in lung cancer.
- Review of studies investigating non-coding RNA in lung cancer pathogenesis.
Main Results:
- Advances in understanding lung cancer genetics have identified actionable mutations.
- Epigenetic alterations are increasingly recognized as key drivers of lung cancer.
- Non-coding RNAs play significant roles in regulating gene expression in lung cancer.
- These molecular insights support the development of targeted therapies.
Conclusions:
- Integrating knowledge of genetics, epigenetics, and non-coding RNA is essential for advancing lung cancer treatment.
- New therapeutic approaches based on molecular mechanisms show promise.
- Continued research into lung cancer's molecular biology will lead to more effective treatments.
